Grimes & Company’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
13,674
-8,016
| -37% | -$146K | 0.01% | 365 |
|
|
2025
Q1 | $430K | Sell |
21,690
-1,122
| -5% | -$22.3K | 0.01% | 251 |
|
|
2024
Q4 | $391K | Sell |
22,812
-473
| -2% | -$8.11K | 0.01% | 277 |
|
|
2024
Q3 | $465K | Sell |
23,285
-16,702
| -42% | -$334K | 0.01% | 242 |
|
|
2024
Q2 | $447K | Sell |
39,987
-5,280
| -12% | -$59K | 0.01% | 231 |
|
|
2024
Q1 | $299K | Hold |
45,267
| – | – | 0.01% | 271 |
|
|
2023
Q4 | $205K | Hold |
45,267
| – | – | 0.01% | 303 |
|
|
2023
Q3 | $162K | Hold |
45,267
| – | – | 0.01% | 283 |
|
|
2023
Q2 | $167K | Hold |
45,267
| – | – | 0.01% | 288 |
|
|
2023
Q1 | $150K | Sell |
45,267
-8,047
| -15% | -$26.6K | 0.01% | 278 |
|
|
2022
Q4 | $207K | Hold |
53,314
| – | – | 0.01% | 267 |
|
|
2022
Q3 | $130K | Hold |
53,314
| – | – | 0.01% | 261 |
|
|
2022
Q2 | $106K | Hold |
53,314
| – | – | 0.01% | 266 |
|
|
2022
Q1 | $98K | Sell |
53,314
-872
| -2% | -$1.6K | 0.01% | 293 |
|
|
2021
Q4 | $76K | Hold |
54,186
| – | – | ﹤0.01% | 294 |
|
|
2021
Q3 | $61K | Hold |
54,186
| – | – | ﹤0.01% | 298 |
|
|
2021
Q2 | $87K | Buy |
54,186
+3,116
| +6% | +$5K | ﹤0.01% | 297 |
|
|
2021
Q1 | $90K | Buy |
51,070
+15,761
| +45% | +$27.8K | ﹤0.01% | 276 |
|
|
2020
Q4 | $69K | Buy |
35,309
+1,809
| +5% | +$3.54K | ﹤0.01% | 264 |
|
|
2020
Q3 | $80K | Buy |
+33,500
| New | +$80K | 0.01% | 244 |
|